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Background and Objectives: The global architecture for providing development assistance for health (DAH)
has become increasing complex in the last decade, with many new funding agencies entering the health sector.
This study presents a detailed picture of European Union (EU) and EU member state originating DAH
between 2006 and 2009; with a specific focus on assessing the extent of complementarity of development
assistance sourced from the EU.
Design: We use a combination of internal EU reporting systems, OECD-DAC creditor reporting system data
and other data sources to estimate DAH flows. Our method uses a line by line project assessment in order to
identify and categorise DAH flows.
Results and conclusions: Our findings show a complex picture of DAH flows  from source, to channel of
assistance, to channel of implementation  that is hard to track at the global level, and rarely comprehensively
and regularly tracked at the country level. While the majority of EU DAH is focused on low and lower middle
income countries there also remains much disparity between countries; and further analysis is required to
better understand whether these imbalances are fair and efficient; or result in overlap. We also recommend
investment in quality control of DAH tracking internally within donor agencies, and investment in the
development of country based systems in order to enable countries and development partners better
harmonise DAH flows.
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T
he global architecture for providing development
assistance for health (DAH) has become increas-
ing complex in the last decade, with many new
funding agencies entering the health sector (1, 2).
Although, in part, these new agencies have been estab-
lished to streamline funding, the changing architecture of
DAH has raised concerns that DAH is becoming
increasingly fragmented (35), potentially creating dupli-
cation and making the process of efficient resource
allocation at the country level challenging (6, 7). These
concerns need to be seen in the context of the global
agreements that govern aid such as the Paris Declaration,
the Accra Agenda for Action and the Busan Partnership
(8). These agreements lay the foundations for increased
co-ordination in DAH and founded a number of core
principles, including that donors work to streamline their
efforts in-country (harmonisation) and for donors and
recipients alike to be jointly responsible for achieving
these goals (mutual accountability) (9).
As a supranational entity, the European Union (EU),
plays a key part in this architecture complementing the
development efforts of EU Member States  not merely as
a 28th donor, but as a coordinator, convenor and policy
maker. In an effort to improve the harmonisation of aid,
in 2007 the EU produced an EU Code of Conduct on
Complementarity and Division of Labour in Development
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Policy, which provides a framework for the implementa-
tion of development assistance between the EU and EU
member states, including the pursuit of more effective
collaboration within the multilateral (ML) aid system.
The mapping of DAH is a necessary pre-requisite for
complementary and effective programming of development
assistance, and harmonization both at the global and
national level (1012). It provides the basic information
necessary for EU donors managing development assis-
tance to plan their financing in a way that maximises the
joint effectiveness of development assistance; and allows
them to identify and reduce the duplication of effort.
It can highlight where many there may be a surfeit of
donors operating, and areas that may be being ignored.
It can be used globally to help EU donors decide which
countries and sectors to operate in, and nationally to
help planners identify resource gaps. It also provides
an essential element of the accountability required by
constituent EU populations.
However, despite this clear need, until recently there
was a dearth of comprehensive data tracking of devel-
opment assistance to the health beyond the formalised
reporting on expenditures by the Organisation of Eco-
nomic Cooperation and Development  Development
Assistance Committee (OECD-DAC). In recent years,
new notable efforts have emerged: primarily the work
conducted by the Institute for Health Metrics and
Evaluation (IHME) and Action for Global Health,
supported by the Bill and Melinda Gates Foundation (1).
This paper aims to complement and extend these
efforts by presenting a detailed picture of EU and EU
member state originating DAH between 2006 and 2009;
with a specific focus on assessing the extent of comple-
mentarity of development assistance sourced from the
EU. We also aim to supplement and inform the methods
used by others tracking aid more globally, by tracking
expenditures from EU registered NGOs; using additional
methods to capture multi-sector expenditures; and finally
through conducting four country based studies to help iden-
tify models for future country focused tracking systems.
Methods
The measurement of DAH is complex, and methods are
continually evolving (1317). We therefore present here a
detailed description of our methods in order to support
those conducting such work in the future, and to allow
for comparison with other studies.
Data sources
The data for this study was obtained from a variety of
different sources. We used internal financial reporting
systems to estimate the amount of aid sourced and
channelled by the EU. We were provided with a raw
dataset of all EU projects. In addition we had direct access
to internal project management records, financial systems
and documents: the CRIS system  Common External
Relations Information System of the European Commis-
sion. For non- EU expenditures we used primarily used the
OECD-DAC creditor reporting system (OECD-CRS).
There have been concerns about the comprehensiveness
of reporting by the various aid agencies reporting to
OECD-CRS. In order to check the completeness of the
OECD-CRS system, we compared the total amounts
reported by the DAC annual aggregates database to the
amounts in the OECD-CRS (coverage ratio). This com-
parison (and some further checks with bilateral sources)
revealed that bilateral reporting was sufficiently compre-
hensive during the period 20069.
For MLs, our initial review of the OECD dataset
revealed some gaps  and therefore in some cases we used
other sources of development assistance reporting. For
the health sector we accessed the dataset on the subject
produced by the IHME (1). We included IHME data for
those MLs who did not report any data to OECD-CRS
(Asian Development Bank, Pan-American Health Orga-
nisation). IHME also provides estimates of aid from US
based NGOs and these were also included in our dataset.
For non-OECD-DAC members we sourced our data
primarily from the AidData database.1 This database
tracks expenditure by scanning project tenders. It does
not capture all non-OECD aid flows, most notably
development assistance from China. While we identified
some data sources on aid from China (e.g. the China
statistical yearbook), these could not be validated and
were therefore excluded from our estimates.
We also included some data on European NGO
expenditure. We were not able to find one comprehensive
source for European development NGOs, so we therefore
limited our work in this area to an ‘NGO scoping
exercise’. We drew up a list of 30 NGOs in each sector
across the EU Member States, consulting/contacting
NGO funding bodies and a variety of development
professionals from several member states. We then
searched NGO websites and official publications to
identify any health and education disbursements. A key
challenge in reporting NGOs development assistance is
double counting  so where possible we excluded any
financing reported by the channels of assistance in the
OECD-CRS dataset.
We were also not able to fully include collective EU
research expenditure that aims primarily at promoting
the economic development and welfare of developing
countries  although we did include that provided by the
European Commission Directorate General for Research
and Innovation. The IHME dataset provides data on
several US-based research funding agencies, such as the
Bill and Melinda Gates Foundation  and this was
included in our estimates.
1http://www.aiddata.org
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Identifying DAH
The task of identifying the proportion of aid that goes to
the health sector is complex. Most of the above data
sources use OECD-DAC purpose codes (18) to classify
development assistance into different sectors. These codes
identify the ‘specific area of the recipient’s economic or
social structure the transfer is intended to foster’. This
approach means that development assistance is not
allocated to sectors on the basis of the types of goods,
services or outputs produced by a project, nor does it
refer to the character of development that a project may
influence, but instead reflects the institutional structure
of the recipient’s country health sector. Beyond this, the
OECD-DAC guidelines suggest that, when there is a
choice between codes, the code should be as specific as
possible. For example, the OECD-DAC guidelines sug-
gest that a project such as the ‘construction of a
tuberculosis clinic’ should be coded under ‘infectious
disease control’ rather than ‘basic health service infra-
structure’. The type of disease is therefore deemed more
important than aspects such as construction or training,
for instance. Finally, each project record includes a
project title and a descriptive text, which provide addi-
tional details on the specific focus of project expenditure,
which helps when classifying expenditure. Moreover,
previous attempts to identify health and education sector
development assistance have shown that there are high
numbers of straightforward coding errors in the OECD-
CRS database (16).
Taking into account the above issues, and our available
time and resources, we took the following approach to
clean and categorise the data from each data source
to arrive at our final estimates for total DAH. The
European Commission’s CRIS database contains
OECD-DAC purpose codes for all its projects. All
projects with a health sector DAC code were selected
(projects that focused on censuses were removed). We
then checked each project to ensure that the title was
relevant to the health sector and, if there was doubt, was
checked on the CRIS database using available project
documents. We then carried out a keyword search on all
projects that did not have a health code. The search was
conducted in four languages: English, French, Portuguese
and Spanish. Lastly, we searched available project docu-
ments on the CRIS database and included them in the
dataset if they were clearly health projects, using a
number of decision rules (available from authors on
request). While it was possible to search and review the
European Commission’s CRIS database and AidData
datasets line by line, the OECD-CRS dataset is much
larger and this approach was not feasible. We therefore
first created an extract of all projects with a health or
education purpose code, using a DAC code filter, and
then a key word search. A summary of the filtered codes
and keywords is available from the authors on request.
Finally, where projects bridged sectors we classified
them into two types: 1) multi-purpose  where all funds
are used simultaneously to achieve multiple objectives
(e.g. training for journalists in HIV awareness). In this
case we allocated the total funds to health; and, 2) multi-
sector  where a project contains funds for several
distinct activities in different sectors. Here we reviewed
the CRIS system to identify the proportion of expendi-
ture by sector, and only included the relevant proportion
in health and education totals. For the OECD we divided
the total project amount by the number of sectors
referred to in the project title or description.
Identifying DAH sourced in the EU
Development assistance can either be reported by the
source or channel of assistance. Typical sources of
development assistance include the national treasuries
of EU Member States or NGOs. The EU is also
considered to be a source of financing  one with its
own resources and budgetary authority. Funds from these
sources are then allocated to different development
agencies which are referred to as channels of assistance.
These agencies fund projects and programmes in low-
and middle-income countries. These include a range of
bilateral government agencies, development funds, ML
agencies and NGOs.
The OECD-CRS database and most other data
sources report development assistance by channel of
assistance for each development agency. To estimate
DAH sourced in the EU some extra steps therefore
need to be taken. For bilateral development assistance
identifying the financing source is straightforward be-
cause they are fully financed by their respective govern-
ments (It should be noted that in this regard that by its
sui generis nature the EU is to be considered a bilateral
agency2). However, for ML agencies the picture is more
complex. The financing of multi-lateral agencies by EU
member states can be divided into two types: core and
non-core funding. Non-core financed DAH is reported
2The EU’s primary legislation (established in the EU’s treaties)
provides that the EU budgetary contributions to development aid
are subject to exclusive EU legislative scrutiny and are implemented
under the EU’s own budgetary authority, with EU institutions
ensuring coherence and control. Whereas the source of EU
development aid is the EU budget  financed wholly from EU
resources  the EU is a bilateral donor in its own right and not a
recipient and disburser of funds of its Member States. On the
contrary, the European Development Fund (EDF) is financed by
extra-budgetary contributions of the EU Member States and can, as
a consequence, be legally considerable as aid from the EU Member
States. The two roles performed by the EU in the development
context are intrinsically linked: the EU budget and the EDF
together endow the EU development policy as defined by the EU
institutions. In this light, the two-fold legal nature of the EU, as a
bilateral donor in its own right on the one hand with a multilateral
function regarding the European Development Fund on the other
hand, has to be considered as sui generis and qualify the EU as a
bilateral donor.
Development assistance for health
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by bilateral funding source; but, in order to avoid double
counting, the OECD-CRS and our other data sources
report all ML DAH projects financed by core funding, by
ML agency not funding source. Therefore, in order to
identify which part of this ML DAH originates from
the EU addition, we used ML core contribution data
as report to the OECD-DAC at an aggregate level and
then allocated these contributions to the health sector
according to the proportions reported by MLs in the
OECD-CRS.
Allocation of regional DAH
A large proportion of development assistance cannot be
allocated to particular countries as it is provided at
a global or regional level. There is also insufficient
supporting information to allocate to countries both in
the EU internal systems and in OECD-CRS project
descriptions. We therefore have not allocated these
projects to specific countries, but left them as regional
unspecified. This underestimates the true development
assistance flows reaching each partner country. We used
the World Bank Classification based on Gross National
Income level (Atlas method) to allocate countries
to different income groups (low-, low middle-, upper
middle- and high- income).
Country case studies
This study also included four country studies (Bangladesh,
Mozambique, Egypt, Burkina Faso) to provide insight
into development assistance flows at the country level.
Specifically, the aim of the country visits was to: 1)
complete the quantitative/qualitative assessment of ex-
penditure (with a focus on local interpretation of global
data); 2) further assess the broader national context
(national priorities and relationship to EU priorities;
indications of national expenditure trends; volume of aid
from other donors; use of aid instruments and coordina-
tion mechanisms); and 3) identify examples of best/worst
practices in aid reporting in a variety of different contexts.
The country case studies were not designed to replicate
global mapping, but to try and identify key gaps from
stakeholders and secondary data sources. Prior to the
visits, an extensive document review was carried out of all
sector policy, plans, expenditure frameworks and expen-
diture reviews (also supplied by the EU country delega-
tions). Additional data was sought from National Health
Accounting (NHA), Ministry of Finance expenditure
reports, and public sector expenditure reviews. Where we
could not get data on public expenditures to match we
used the official government data. For other domestic
expenditures we primarily relied on NHA data from local
and if not available global reports. In addition, a web
search was carried out to find project documents for all
the large projects we had identified.
This was followed by country visits carried out between
December 2011 and May 2012, each between 1 and 2
weeks, to conduct on interviews with key stakeholders. Key
stakeholders were identified in close co-operation with the
EU delegation, and based on a list provided by the study
team; some respondents were referred by other stake-
holders. Meetings were held with donor representatives,
government officials (from sector and finance ministries)
and representatives from NGOs (see detailed country
reports for a list of key stakeholders interviewed). In total
91 stakeholders were interviewed. All freely agreed to be
interviewed and their anonymity has been safeguarded.
The 1 to 3 hour semi-structured interviews were con-
ducted using a topic guide. The interviews were con-
ducted by interviewers with training and experience in
health and education sector development and financing.
Extensive notes were taken and many of the interviews
were recorded. Where feasible, additional stakeholder
focus group meeting were held in some countries, and key
findings were reported back to stakeholders. In addition,
to further contextualise and understand the response, a
number of additional interviews were then conducted
with stakeholders who were not available during the visit
and, in some cases, with key experts in a particular field.
Finally, further documentation that was obtained during
the interviews was also reviewed.
Results
Global mapping
Between 2006 and 2009, the EU and its Member States
disbursed around t20.4 billion in DAH in low- and
middle-income countries (Fig. 1).
This is in the context of collective EU development
assistance disbursements of approximately t59.9 billion
development assistance disbursed to the health sector
globally. The proportional contribution of the collective
EU to the health sector (34%) is substantially lower than
in other areas, such as the education sector (66%) 
primarily due to the relatively high levels of DAH
provided by the United States, in particular for HIV
programmes. EU sourced DAH commitments and dis-
bursements to both the health and education sectors
increased in real terms, in line with global aid trends.
However, the rate of increase in EU DAH to developing
countries was lower than the rate of increase by donors
from outside the EU collectively. The EU Member States
that made the largest DAH contributions were the UK,
France, Germany, and the Netherlands. Other donors
such as Spain, Sweden, Italy and Ireland also made
sizable contributions. Figure 2 shows that the majority
of collective EU DAH was disbursed through the EU
Member States’ own bilateral development agencies
and the EU’s bilateral channel of assistance, although
sizable amounts were also disbursed through ML agen-
cies, in particular the Global Fund for AIDS, TB and
Malaria and the World Bank (IDA). We also identified
Anna Vassall et al.
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substantial funding through NGOs, particularly from
France through Me´decins Sans Frontie`res.
Figure 3 presents the pattern of global DAH provided
by NGO, bilateral and ML channels of assistance. It can
be seen that most growth is observed through increased
channelling through NGOs, although the role of multi-
lateral agencies has slightly increased. It should also be
noted that significant amounts of DAH reported here
as bilateral development assistance are subsequently
provided to ML agencies to implement development
activities.
Figure 4 shows how each of the top 20 collective EU
recipient countries are funded by the different EU bilateral
channels of assistance. Countries such as India, Egypt,
Afghanistan and Indonesia benefit from particularly large
contributions by specific donors. However, most of these
top 20 countries appear to benefit from the interest of
numerous EU Member State bilateral agencies; and in this
respect can be seen as ‘donor darlings’, but also may suffer
from highly fragmented DAH at the country level.
Conversely, some countries may also be considered
‘donor orphans’. Figure 5 shows the per capita disburse-
ment of DAH over the entire period 2006 to 2009 for
the 20 low- and lower middle-income countries which
received the lowest per capita aid globally. Globally
Iran, Columbia, Algeria, Belarus and China received
the least per capita development assistance to their health
sectors. Of the bottom 20 countries, the EU contributes a
significant proportion of their limited DAH in Syria,
Serbia and Burma.
Most collective EU DAH was provided to low-income
countries but this proportion varies considerably by
donor country. The EU provides slightly around 50%
of its total DAH to low income countries (and 85% to
low- and low middle-income countries combined). This is
in part driven by the relatively high levels of development
assistance provided to countries such as Egypt and
South Africa. It should be noted though that this overall
figure does not take account of the distribution at the
country level  and the recent thematic evaluation noted
the good practice by the EU of geographically target-
ing specific areas in several countries in order to reach
the poorest. Several EU Member States, Sweden, the
Netherlands, Slovakia, Estonia, Denmark, Belgium and
Ireland, provide over 70% of their DAH to low-income
countries. Almost 30% of development assistance to
health provided by the EU and its Member States goes
to fragile states, as defined by the OECD.3
The EU provides the majority of its DAH to basic
health care (60%). The second largest expenditure
category is health policy (20%). Ten percent of its DAH
is allocated to population and reproductive health, and
another 10% to HIV/AIDS. A large proportion of
collective EU (over 20%) and global DAH (over 30%)
cannot be allocated to a specific sub-sector. If it is
assumed that this unallocated DAH goes towards basic
health services then there is less difference between the
sub-sectoral allocations of DAH between the EU and
other EU donors. We found some differences in the
priorities of different EU Member States. The UK and
France, for instance, allocate relatively high proportions
to health policy, education and research, and Germany
and the UK relatively high proportions to sexually
transmitted diseases and HIV/AIDS.
3The OECD list is derived from the World Bank-African Develop-
ment Bank-Asian Development Bank harmonised list of fragile and
post-conflict countries. It is not an official OECD-DAC list.
Fig. 1. Global development assistance to health by type of source and year (millions of 2009 t).
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Country case studies
We identified several additional sources of data on DAH
available locally. In most countries, ‘on-budget’ develop-
ment assistance had been captured in public expenditure
reviews, although these were not available routinely. For
the health sector, sporadic data was available from
National Health Accounts (NHAs) (although more
routinely in Burkina Faso and Egypt than in other
countries). Some countries were also participating in
National Aid Spending Assessments supported by UN-
AIDS. The degree of institutionalisation of different
expenditure tracking varied widely by country, but for
the most part NHAs were not institutionalised within any
domestic governmental structure. However, most respon-
dents were aware that a NHA had taken place and had
used some of the data within it.
In addition, in Burkina Faso and Mozambique we
found efforts to institutionalise development assistance
Fig. 2. Collective EU DAH disbursement by source and type of channel of assistance 2006 to 2009 (millions of 2009 t).
Fig. 3. Global Development assistance to health by type of channel of assistance and year (millions of 2009 t).
Anna Vassall et al.
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reporting in government ministries. In Burkina Faso,
there are several sources of information available. These
include the ‘Direction Ge´ne´rale de la Coope´ration’
(General Directorate for External Cooperation) in the
Treasury, which is responsible for the follow-up of the
external aid and the elaboration of the annual report on
cooperation for development. In addition, the ‘Direction
Ge´ne´rale de l’Economie et de la Planification’ (General
Directorate for Economy and Planning) (DGEP) in the
Ministry of Finance is responsible for the follow up of
Fig. 4. Top 20 recipient countries collective EU DAH disbursement by bilateral channel of assistance 2006 to 2009 (millions of
2009 t).
Fig. 5. Bottom 20 recipient countries (in terms of per capita DAH) DAH disbursement by type of channel of assistance
(millions of 2009 t).
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Public Investment Programme (PIP) of the state as part
of its role of monitoring government economic policies.
Mozambique also has various mechanisms to track
partner health expenditure. Since 2000, the Ministry of
Health, with support from donors, has systematically
gathered information on donor expenditure and pledges
through surveys. This system is now called Inque´rito de
Fundos Externos (IFE) and is updated annually. Sophis-
tication and comprehensiveness have improved in each
update and the IFE is now a well-established monitoring
tool, providing details including the type of modality
used by donors, the on-budget status of each contribu-
tion, geographic information and the level of care
distribution. The information collected in the IFE is
used not only to produce sector analysis, such as the
NHAs, but also for planning, since it is used for the
Medium-term Expenditure Framework (MTEF), which
forecasts future financial envelopes and expenditure.
An additional tracking system in Mozambique is
ODAMOZ, an online-based tool managed by the Min-
istry of Planning and Development to collect data on
partner contributions in all sectors. The process of data
gathering is based on auto-reporting of partners and the
website (www.odamoz.org.mz) supporting the database
allows the production of customised reports aimed at
boosting transparency and allowing managers and re-
searchers to have access to this data. Unfortunately, not
all donors report to ODAMOZ, undermining the effort
and resulting in the ODAMOZ database not being
complete. However, the remaining donors are reportedly
considering joining this platform in the coming years.
Overall we found the amounts in our global mapping
database to be broadly consistent with those found from
local data sources, but there were several key omissions;
particularly on funding channelled through NGOs. The
other key omission was data from the Asian Develop-
ment Bank (we were unable to obtain disbursement data
by country from the Asian Development Bank globally)
and the Islamic Development Bank. We also identified
additional projects by a number of other donors who do
not report to OECD-DAC, including China and Cuba 
but we were able to obtain limited ad hoc information on
expenditures from these donors at the country level. On
the other hand, we also found that the global dataset was
more comprehensive than local reporting mechanisms.
Not all projects were captured at the local level,
particularly contributions from smaller donors or those
who may not have local offices, or whose aid flows from
regional organisations.
However, although the broad amounts were consistent,
local level data is considerably more comprehensive when
describing the character of DAH flows. We identified a
small number of additional straightforward coding errors
beyond those already identified in the line by line review.
We were also able to better identify DAH from different
donors contributing towards a specific sector programme
or pooled fund. Overall we found that global level DAH
can appear to be more fragmented than it is, as often
sector investments or spending within one project
appears as multiple project lines. We also found the
channel (of implementation) coding in the global dataset
to be inaccurate for several projects in all countries, with
most projects being coded under ‘other’, when it was
often clear at the country level that it was going to a
particular channel. The main concern expressed by
respondents about OECD-DAC reporting at the country
level was double counting funds channelled through
intermediaries such as UNICEF. However, we were
not able to verify the extent of this during our country
visits.
Finally, it should also be noted that despite the
existence of reports and systems, we also found a very
mixed picture regarding the use of this country level data.
Although the use of data from routine systems was more
widespread than one off exercises such as NHA, we
found many instances where donors and government
(staff at the sectoral level) were not aware or using it.
Where there was a dearth of local DAH data, surprisingly
few of the respondents mentioned this to be a major
impediment to sector co-ordination, planning and mon-
itoring. However, where both the production and use of
data had been institutionalised, particularly within sector
review processes, there was much more awareness of the
data by the donors and the government.
Discussion and conclusions
Our findings above show a complex picture of DAH
flows  from source, to channel of assistance, to channel
of implementation  that is hard to track at the global
level, and rarely comprehensively and regularly tracked at
the country level. While the majority of EU DAH is
focused on low and lower middle income countries there
also remains much disparity between countries; and
further analysis is required to better understand whether
these imbalances are fair and efficient. This data was
presented to two meetings of lead health advisors from
EU member states and can be used by donors and others
to begin to identify possible overlap and areas for
improved harmonisation.
However, while the reporting of EU Member States to
OECD-DAC has much improved in terms of comprehen-
siveness in the past decade, we also find there is still room
for improvement (12). Most EU donors compile their
OECD-DAC extract from project management systems
that may not neatly fit the OECD-DAC requirements,
with various staff entering the original data. While staff
may be given guidance on how to enter data, it is clear
that there are many aspects that may be interpreted
differently at the data entry level. This process needs to be
quality controlled internally. For example the quality of
Anna Vassall et al.
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reporting from the European Commission has substan-
tially increased since 2006, following the establishment of
review procedures and the systematic checking of the
OECD-DAC submission.
Furthermore comprehensive sub-sector coding in
health presents an insurmountable challenge unless it is
possible to use a matrix approach (as in NHA) or enter
multiple purpose codes. Without this it may be hard to
identify where (if any) duplication of effort occurs.
However, it is questionable whether efforts should con-
tinue at the global level in this regard  or focus on
developing a new categorisation related to levels of the
health system. Given the centrality of strengthening
health systems to EU development policy in health,
expending resources on separate sub-sector and disease
expenditure tracking efforts is less important than track-
ing by different health system or sub-national levels.
Health system functions could also be further clarified in
line with recent analytical frameworks.
In addition, there are several areas that would assist or
complement OECD-DAC. Possible supplementary exer-
cises could include the following: a complete assessment
of all EU Member States’ contributions as a source of
development assistance through ML agencies; and devel-
opment assistance flows from NGOs registered in EU
Member States. The EU could consider establishing
regular surveys to complement the OECD-DAC data in
this regard.
Although much of the focus of development assistance
tracking is at the global level, if harmonisation is to be
achieved in practice, context is defining, and the real
need and gap is therefore at the country level. There is
considerable room for improvement in the country level
tracking of development assistance to health and educa-
tion. Given the large amounts of DAH funding overall,
proportionally modest investments should be made in a
number of countries, linked with sector programming to
track DAH. Although these national efforts should be
relevant to the country, where possible it makes sense to
build on global efforts and encourage some compatibility
of data across countries. A possible starting point would
be to do trial projects in a few countries, based on
experiences such as those in Mozambique for the health
sector, facilitated by the EU, but with some attention to
developing a system that has the potential to both draw
from and feed into both OECD-DAC and NHA efforts,
rather than starting with definitions and coding afresh.
Unlike the OECD-DAC, however, national level efforts
need to link into national planning timeframes and bud-
getary structures to be of use in national policy and
planning  and if the two systems come into conflict,
then the national requirement should always take priority.
Finally, few EU donor respondents in our country
studies demonstrated knowledge of the issues in devel-
opment assistance reporting. In addition, even where
there was data available, few were aware of levels of
government funding to the sector or how to assess areas
such as sector and sub-sector expenditure. This may be a
sign of over-stretched resources in donor offices, and the
fact that those working at a sectoral level do not have a
background in finance or economics. Therefore further
support may be required at the country level to encourage
all development partners to engage more fully in devel-
opment assistance tracking efforts.
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